Research quality in the supplement space varies enormously — from rigorous RCTs with hundreds of participants to single-cell studies that have never been replicated in humans. This post examines the clinical evidence for Niacinamide specifically, separating what the trials actually show from what manufacturers claim.
The evidence base: what we are working with
Key citations: PMID 22018597 (Soma 2014, acne RCT vs clindamycin), PMID 24711159 (Chen 2015, skin aging RCT), PMID 24697559 (Lim 2015, melanin reduction study).
The clinical evidence for Niacinamide is rated Grade B, meaning good clinical evidence from RCTs, some limitations.
How Niacinamide produces its effects
Niacinamide is converted to NAD+, which is essential for cellular energy production, DNA repair via poly(ADP-ribose)
Understanding the mechanism matters because it explains both the benefits and the limitations. Niacinamide works through NAD+ — which is why the effects appear at the timescale they do, and why consistent dosing is more important than perfect timing.
What the numbers mean in practice
The improvement data above represents the average response seen across cited trials. A few important caveats:
Baseline matters. The larger the deficit from optimal, the larger the measurable improvement. Someone with severely depleted levels will see bigger changes than someone already in the optimal range.
Consistency matters more than dose. Missing doses regularly is more damaging to outcomes than taking a slightly lower dose consistently.
Individual variation is real. Some people are genetic non-responders to specific supplements. If you have tracked relevant markers and see no movement at 12 weeks on an adequate dose, the supplement may not be the right choice for your biochemistry.
Interpreting your own blood results
The markers most relevant to Niacinamide are NAD+. If you have a recent blood test, upload it to the SacredBod Analyzer to see where your levels sit and whether Niacinamide is likely to be relevant for your specific results.
Summary of the evidence
Niacinamide has a clinically meaningful effect on skin-aging in adults with relevant deficiency or suboptimal status. The evidence quality justifies its use as part of a targeted supplement protocol. It does not justify indefinite use without tracking outcomes or ignoring the safety profile outlined in the full guide.
Supplements mentioned
Niacinamide
b-vitamin · 500 mg per day (skin/general); 500 mg twice daily (skin cancer prevention) · 100 caps
People also ask
What does "Evidence Grade B" mean for Niacinamide?
How long do the benefits of Niacinamide last?
How do I track whether Niacinamide is working for me?
Keep reading
Thiamine (B-1): what the research actually shows
A clinical evidence review of Thiamine (B-1) — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Riboflavin (B-2): what the research actually shows
A clinical evidence review of Riboflavin (B-2) — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Pantothenic Acid: what the research actually shows
A clinical evidence review of Pantothenic Acid — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.